Literature DB >> 7682308

Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms.

H Tohgi1, T Abe, S Takahashi, J Takahashi, H Hamato.   

Abstract

We evaluated the concentrations of free and total serotonin (5-hydroxytryptamine, 5-HT) and its related substances in the cerebrospinal fluid from patients with Parkinson's disease (PD). The concentrations of total 5-HT, 5-hydroxytryptophan, kynurenine and 3-hydroxykynurenine decreased significantly in PD patients compared with controls. The concentration of total 5-HT had significant negative correlations with Hoehn and Yahr's stages, the severity of rigidity, akinesia and gait freezing; the correlation with gait freezing was most conspicuous.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682308     DOI: 10.1016/0304-3940(93)90111-w

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Concentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson's patients with severe postural instability and gait disorders.

Authors:  R P Iacono; S M Kuniyoshi; J R Ahlman; G J Zimmerman; G Maeda; R D Pearlstein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  Concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism compared to Parkinson's disease patients.

Authors:  H Tohgi; T Abe; M Saheki; K Yamazaki; T Murata
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  The selective 5-HT1A receptor antagonist WAY-100635 inhibits neuronal activity of the ventromedial prefrontal cortex in a rodent model of Parkinson's disease.

Authors:  Jian Cao; Jian Liu; Qiao-Jun Zhang; Tao Wang; Shuang Wang; Ling-Na Han; Qiang Li
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

4.  Parkinson patients have a presynaptic serotonergic deficit: A dynamic deep brain stimulation PET study.

Authors:  Louise M Jørgensen; Tove Henriksen; Skirmante Mardosiene; Sune H Keller; Dea S Stenbæk; Hanne D Hansen; Bo Jespersen; Carsten Thomsen; Pia Weikop; Claus Svarer; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-18       Impact factor: 6.200

5.  The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing.

Authors:  Nóra Török; Rita Török; Zoltán Szolnoki; Ferenc Somogyvári; Péter Klivényi; László Vécsei
Journal:  Parkinsons Dis       Date:  2015-02-17

6.  Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease.

Authors:  Anna L Stern; Nirinjini Naidoo
Journal:  Springerplus       Date:  2015-01-17

Review 7.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

8.  Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.

Authors:  Satoru Morimoto; Masaki Takao; Hiroyuki Hatsuta; Yasushi Nishina; Tadashi Komiya; Renpei Sengoku; Yuta Nakano; Akiko Uchino; Hiroyuki Sumikura; Yuko Saito; Kazutomi Kanemaru; Shigeo Murayama
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

9.  A Neurocomputational Model of the Effect of Cognitive Load on Freezing of Gait in Parkinson's Disease.

Authors:  Vignesh Muralidharan; Pragathi P Balasubramani; V Srinivasa Chakravarthy; Moran Gilat; Simon J G Lewis; Ahmed A Moustafa
Journal:  Front Hum Neurosci       Date:  2017-01-09       Impact factor: 3.169

10.  Low plasma serotonin linked to higher nigral iron in Parkinson's disease.

Authors:  Leslie C Jellen; Mechelle M Lewis; Guangwei Du; Xi Wang; Martha L Escobar Galvis; Stanislaw Krzyzanowski; Colt D Capan; Amanda M Snyder; James R Connor; Lan Kong; Richard B Mailman; Patrik Brundin; Lena Brundin; Xuemei Huang
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.